199 related articles for article (PubMed ID: 19790013)
1. The Immunotherapeutics & Vaccine Summit--CHI's fourth annual meeting. Preclinical/clinical development of immunotherapies and vaccines. 17-19 August 2009, Providence, RI, USA.
Butterfield LH
IDrugs; 2009 Oct; 12(10):633-5. PubMed ID: 19790013
[TBL] [Abstract][Full Text] [Related]
2. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
Jones SD
IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
[TBL] [Abstract][Full Text] [Related]
3. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
Jones SD
IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
[TBL] [Abstract][Full Text] [Related]
4. Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference.
Terrett N
IDrugs; 2010 Apr; 13(4):209-13. PubMed ID: 20373245
[TBL] [Abstract][Full Text] [Related]
5. High-Content Analysis--CHI's Seventh Annual Conference--Flow Cytometry in Drug Discovery and Development.
Robinson JP
IDrugs; 2010 Mar; 13(3):153-5. PubMed ID: 20191428
[TBL] [Abstract][Full Text] [Related]
6. Molecular Medicine - CHI's 17th International Tri-Conference: Mastering Medicinal Chemistry - CHI's Seventh Annual Conference.
Semple G
IDrugs; 2010 Apr; 13(4):214-8. PubMed ID: 20373246
[TBL] [Abstract][Full Text] [Related]
7. World Vaccine Congress Lyon - Terrapinn's 11th Annual Congress.
Sovran L
IDrugs; 2009 Dec; 12(12):738-41. PubMed ID: 19943212
[TBL] [Abstract][Full Text] [Related]
8. High-Content Analysis--CHI's Seventh Annual Conference--Developments in HCA and Pathway Analysis.
Robertson FM
IDrugs; 2010 Mar; 13(3):149-52. PubMed ID: 20191427
[TBL] [Abstract][Full Text] [Related]
9. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
Plane G
IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
[TBL] [Abstract][Full Text] [Related]
10. HDAC Inhibitors--CHI's Third Annual Conference.
Rosato RR
IDrugs; 2010 Jan; 13(1):13-5. PubMed ID: 20024840
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Manufacturing--Second Annual visiongain Conference.
McPherson C
IDrugs; 2010 Jul; 13(7):437-9. PubMed ID: 20582865
[TBL] [Abstract][Full Text] [Related]
12. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
13. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
Thorneloe KS
IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
[TBL] [Abstract][Full Text] [Related]
14. American Society of Gene & Cell Therapy--13th Annual Meeting.
Romano G
IDrugs; 2010 Jul; 13(7):444-7. PubMed ID: 20582867
[TBL] [Abstract][Full Text] [Related]
15. American Chemical Society--238th National Meeting & Exposition. Developments in medicinal chemistry: part 1. 16-20 August 2009, Washington DC, USA.
Gater D; Macauley D
IDrugs; 2009 Oct; 12(10):605-7. PubMed ID: 19790004
[TBL] [Abstract][Full Text] [Related]
16. Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company.
Moise L; De Groot A; Marcello A; Tassone R; Martin W; Cousens L
R I Med J (2013); 2013 Feb; 96(2):19-21. PubMed ID: 23641421
[TBL] [Abstract][Full Text] [Related]
17. Terrapinn's world influenza congress Europe 2009. Part 2.
Veryard C
IDrugs; 2010 Feb; 13(2):78-9. PubMed ID: 20127556
[TBL] [Abstract][Full Text] [Related]
18. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
Seneci P
IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
[No Abstract] [Full Text] [Related]
19. PepTalk--CHI's Ninth Annual Meeting--Engineering Protein & Peptide Therapeutics: Peptides.
Craik D
IDrugs; 2010 Mar; 13(3):156-8. PubMed ID: 20191429
[TBL] [Abstract][Full Text] [Related]
20. An overview of FDA-approved vaccines & their innovators.
Griesenauer RH; Kinch MS
Expert Rev Vaccines; 2017 Dec; 16(12):1253-1266. PubMed ID: 28931331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
